🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, prospective, multicenter, open-label, Phase III clini...
Status
Active Not Recruiting
Location
Sir Run Run Shao hospital
Start Date
2024-07-29
Trial ID
NCT06507371
This Phase 3 study was a randomized, double-blind, placebo-controlled, mult...
Status
Completed
Location
The Second Hospital of Anhui Medical University
Start Date
2019-07-22
Trial ID
NCT04005716
Treatments Being Tested
The primary scientific question of interest of this study is whether the co...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-09-15
Trial ID
NCT05809895
Treatments Being Tested
This study is a single-center, prospective, open-label, randomized controll...
Status
Completed
Location
Fourth Hospital of Hebei Medical University
Start Date
2021-09-01
Trial ID
NCT05086627
Treatments Being Tested
Esophageal squamous cell carcinoma (ESCC) is a common malignant tumor world...
Status
Not Yet Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2026-04-01
Trial ID
NCT07531979
Treatments Being Tested
To evaluate the safety and preliminary efficacy of preoperative chemotherap...
Status
Recruiting
Location
The affiliated hospital of Qingdao university
Start Date
2025-06-01
Trial ID
NCT06647680
Neoadjuvant Short-Course Radiotherapy Followed by Tislelizumab Plus Chemoth...
Status
Not Yet Recruiting
Location
Tangdu Hospital, Fourth Military Medical University
Start Date
2026-07-10
Trial ID
NCT07678580
In clinical practice, some patients cannot tolerate concurrent chemoradioth...
Status
Recruiting
Location
Zibo Municipal Hospital
Start Date
2024-01-13
Trial ID
NCT07085182
Treatments Being Tested
SBRT Combined with CAPEOX, Bevacizumab, and PD-1 Inhibitor in RAS-Mutant, M...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02
Trial ID
NCT06835179
Treatments Being Tested
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994